Indication
Episodic cluster headache
Episodic cluster headache is a primary neurovascular headache disorder classified under the trigeminal autonomic cephalalgias, primarily affecting adults and demonstrating a notable male predominance. Read more about Episodic cluster headache
1 drugs 1 manufacturers
Drugs that treat it
Common Episodic cluster headache therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEpisodic cluster headache is a primary neurovascular headache disorder classified under the trigeminal autonomic cephalalgias, primarily affecting adults and demonstrating a notable male predominance.
It is characterized by recurring cluster periods, or bouts, typically lasting from seven days to one year, separated by pain-free remission intervals lasting at least three months.
During active bouts, patients experience excruciating, strictly unilateral pain localized to the orbital, supraorbital, or temporal regions that lasts 15 to 180 minutes and recurs up to eight times daily, often exhibiting strict circadian and circannual periodicity.
Pathophysiologically driven by hypothalamic dysregulation and trigeminovascular system activation, attacks are accompanied by ipsilateral cranial autonomic symptoms—such as lacrimation, conjunctival injection, nasal congestion, and ptosis—as well as pronounced physical restlessness.
- nih.gov
Episodic cluster headache is a primary neurovascular headache disorder classified under the trigeminal autonomic cephalalgias, primarily affecting adults and demonstrating a notable male predominance
- nih.gov
Episodic cluster headache is a primary neurovascular headache disorder classified under the trigeminal autonomic cephalalgias, primarily affecting adults and demonstrating a notable male predominance
- nih.gov
Episodic cluster headache is a primary neurovascular headache disorder classified under the trigeminal autonomic cephalalgias, primarily affecting adults and demonstrating a notable male predominance During active bouts, patients experience excruciating, strictly unilateral pain localized to the orbital, supraorbital, or temporal regions that lasts 15 to 180 minutes and recurs up to eight times daily, often exhibiting strict circadian and circannual periodicity Pathophysiologically driven by hyp...
- ichd-3.org
It is characterized by recurring cluster periods, or bouts, typically lasting from seven days to one year, separated by pain-free remission intervals lasting at least three months
- nih.gov
It is characterized by recurring cluster periods, or bouts, typically lasting from seven days to one year, separated by pain-free remission intervals lasting at least three months Pathophysiologically driven by hypothalamic dysregulation and trigeminovascular system activation, attacks are accompanied by ipsilateral cranial autonomic symptoms—such as lacrimation, conjunctival injection, nasal congestion, and ptosis—as well as pronounced physical restlessness
- nih.gov
During active bouts, patients experience excruciating, strictly unilateral pain localized to the orbital, supraorbital, or temporal regions that lasts 15 to 180 minutes and recurs up to eight times daily, often exhibiting strict circadian and circannual periodicity
- ichd-3.org
During active bouts, patients experience excruciating, strictly unilateral pain localized to the orbital, supraorbital, or temporal regions that lasts 15 to 180 minutes and recurs up to eight times daily, often exhibiting strict circadian and circannual periodicity
- nih.gov
Pathophysiologically driven by hypothalamic dysregulation and trigeminovascular system activation, attacks are accompanied by ipsilateral cranial autonomic symptoms—such as lacrimation, conjunctival injection, nasal congestion, and ptosis—as well as pronounced physical restlessness
Personalize your experience
Follow Episodic cluster headache and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.